| July 1 |
EMEA Recommends a New Warning for Epoetins for Their Use in Cancer
Patients |
| July 2 |
Summary Judgment Granted for Seroquel Patent Litigation |
| July 2 |
Publicis Groupe Acquires Kekst and Company, Incorporated
World’s Premier Strategic and Financial Public Relations Firm |
| July 2 |
Pfizer Changes Its Funding of Continuing Medical Education in the
U.S. |
| July 3 |
Shire to Add New Orphan Drug to its HGT Portfolio - EU Launch
Imminent |
| July 3 |
Adolor Provides Update on Entereg (alvimopan) OBD Program |
| July 7 |
APP Pharmaceuticals to Be Acquired by Fresenius |
| July 7 |
Bentley Pharmaceuticals & Teva Pharmaceutical Industries Ltd.
Merger Consideration Established at $14.82 Per Share |
| July 7 |
Introgen Reduces Development Staff to Focus on Commercial
Activities after Advexin Regulatory Filings in U.S. and Europe |
| July 7 |
Global Pharmaceutical Industry at a Crossroads |
| July 8 |
Novartis Completes Purchase of Minority Interest in Alcon |
| July 8 |
Giaconda Suspends Hepaconda Phase II Trial to Carry Out Dose
Ranging |
| July 8 |
Cardinal Health Formalizes Consolidation of Businesses Into Two
Primary Operating and Reporting Segments |
| July 8 |
MediGene Puts Clinical Phase I Study with RhuDex On Hold |
| July 9 |
Lilly to Acquire SGX Pharmaceuticals |
| July 9 |
New Casa Report Finds: Most Web Sites Selling Prescription Opioids,
Stimulants and Depressants Require No Prescription |
| July 9 |
Solvay Pharmaceuticals S.A. Increases to Eur 6.50 Per Share Its
Initial Tender Offer to Acquire Innogenetics |
| July 9 |
Second Quarter Health Care M&A Strongest In Years According To
New Report From Irving Levin Associates, Inc. |
| July 9 |
FDA Revises Process for Responding to Drug Applications |
| July 9 |
Wyeth's Motion to Overturn Punitive Damages Award Granted by
Arkansas Court |
| July 10 |
Novartis Buys Additional 51.7% Stake in Speedel and Announces Plans
to Acquire Remaining Shares in a Mandatory Public Tender Offer |
| July 10 |
PhRMA Revised Marketing Code Reinforces Commitment to Responsible
Interactions With Healthcare Professionals |
| July 10 |
Ratio-morphine Tablets Recalled in Canada Due to Risk of Accidental
Overdose |
| July 10 |
Insmed Announces First Human Bioequivalence Data for a Follow-on
Biologic by a U.S. Company |
| July 10 |
Johnson & Johnson Announces Commitment To Adopt Revised PhRMA
Marketing Code for Responsible Interactions With Healthcare
Professionals |
| July 10 |
New Study Shows Physicians Use Numerous Sources to Inform
Prescribing Decisions for Patients |
| July 10 |
Enlight Biosciences Launched in Collaboration with Merck & Co.,
Inc., Pfizer, and Eli Lilly |
| July 10 |
Pharmaceutical Companies Spend More in Vermont in 2007, Says
Attorney General Sorrell |
| July 10 |
Access Pharmaceuticals Signs Merger Agreement to Acquire MacroChem
Corp. |
| July 10 |
FDA MedWatch - Herceptin 440mg Vials & BWFI Diluent-Complaints
of Damaged and Broken Vials That May Lead to a Loss of Sterility |
| July 10 |
Templeton Asset Management Rejects Sun Pharmaceutical's Tender
Offer for Taro Pharmaceutical |
| July 11 |
Momenta Pharmaceuticals Announces Filing of Abbreviated New Drug
Application with a Paragraph IV Certification for Generic Version
of Copaxone |
| July 11 |
Richard F. Selden, Former CEO of a Massachusetts Biotechnology
Company, Settles SEC Fraud Action |
| July 11 |
Statement of the Coalition for Healthcare Communication On the
Value of Independent Commercial Providers of CME |
| July 14 |
Ranbaxy Issues Statement on DOJ Investigation of Drugs Sold in U.S. |
| July 14 |
Alcon Terminates the Development of Anecortave Acetate in
Age-Related Macular Degeneration |
| July 14 |
Ortho Biotech and Amgen Resolve Antitrust Litigation |
| July 14 |
Neurogen Announces Suspension of Insomnia Study with Adipiplon |
| July 14 |
FDA Updates Label for Avandia to Include Clinical Findings
Demonstrating Sustained Glycemic Control for Up to Five Years |
| July 14 |
Actelion and GlaxoSmithKline Enter Into Exclusive Collaboration to
Realise the Full Potential of Almorexant in Sleep Disorders and
Beyond |
| July 14 |
Two New Jersey Hormone Therapy Lawsuits Dismissed |
| July 14 |
FDA MedWatch- Avastin (bevacizumab) and Sunitinib Malate- Reports
of Microangiopathic Hemolytic Anemia In Patients Treated With This
Combination |
| July 15 |
Genentech Announces Second Quarter 2008 Results |
| July 15 |
Company Suspended From ABPI Membership Over Breaches Of Code Of
Practice |
| July 15 |
Infinity Provides Update On Phase 2 Signal-Finding Clinical Study
of IPI-504 in Advanced Prostate Cancer |
| July 15 |
Jerini Receives European Commission Approval for Firazyr
(Icatibant) in the Treatment of HAE |
| July 15 |
MediGene Publishes Update on RhuDex Incident |
| July 16 |
BioAlliance Pharma Suspends the Phase II/III Trial of Doxorubicin
Transdrug in Primary Liver Cancer |
| July 16 |
Global Market for Cancer Therapies Slated for High Growth Through
2013 |
| July 16 |
Bristol-Myers Squibb Agrees to Pay More Than $9 Million to
Massachusetts Medicaid Program to Settle Allegations of Improper
Marketing and Business Practices |
| July 16 |
Procter & Gamble Announces Organizational Changes |
| July 16 |
Concerned Shareholders of Biovail Pleased with Court Order for
Biovail AGM |
| July 16 |
SEC Charges Mayor of Beaufort, S.C., With Insider Trading in Stock
of Biotech Company |
| July 16 |
Sciele Pharma Announces That the FDA Has Issued an Approvable
Letter for the Head Lice Treatment |
| July 16 |
Concerned Shareholders Respond to Biovail's Press Release |
| July 17 |
Baxter Raises Full-Year 2008 Outlook Following Strong
Second-Quarter Financial Results |
| July 17 |
Daiichi Sankyo and Ranbaxy Confirm Deal is Binding and Final, Allay
Market Rumour and Speculation |
| July 17 |
Wyeth and Impax Announce Final Settlement of Effexor XR Patent Suit |
| July 17 |
FDA Advisory Committee Provides Opinion of Doribax for the
Treatment of Hospital-Acquired Pneumonia |
| July 17 |
Novartis Gains Momentum with Strong Performance in First Half of
2008 from Portfolio Focused on Growth Areas of Healthcare |
| July 17 |
Bellus Health Announces Closing of Innodia Acquisition |
| July 17 |
New Report: Investment in Disease Prevention Could Save America
More than $16 Billion in Five Years |
| July 17 |
Statement: NIAID Will Not Move Forward with the Pave 100 HIV
Vaccine Trial VRC |
| July 18 |
Teva to Acquire Barr |
| July 18 |
Gilead Sciences Announces Second Quarter 2008 Financial Results |
| July 18 |
Zentiva Responds to Sanofi-Aventis CZK 1,050 per Share Voluntary
Offer |
| July 21 |
Roche Makes Offer to Acquire All Outstanding Shares of Genentech
for US$89.00 Per Share in Cash |
| July 21 |
Roche Proposes to buy Full Stake in Genentech - Interview With
Chairman |
| July 21 |
Biota Holdings Limited (ASX:BTA) and GSK Conclude Litigation
Through Mediation |
| July 21 |
FDA Rule and Companion Guidance Make Early Stage Clinical Drug
Development Safe and Efficient |
| July 21 |
Roche Posts Very Good Results: Strong Market Outperformance –
Guidance Confirmed |
| July 21 |
Genentech Announces Receipt of Proposal From Roche |
| July 21 |
Independent Analyses of the SEAS, SHARP and IMPROVE-IT Studies of
Ezetimibe |
| July 22 |
Schering-Plough Reports Financial Results for Second Quarter of 2008 |
| July 22 |
Forest Laboratories, Inc. Reports Fiscal First Quarter 2009 Earnings Per Share of $0.79, Including $0.08 per Share Charge for Agreement Termination |
| July 22 |
Roche Acquires Mirus to Advance Research in the Field of RNAi Delivery |
| July 22 |
Biogen Idec Reports Second Quarter 2008 Results |
| July 22 |
Merck Reports Second-Quarter 2008 Financial Results |
| July 23 |
Roche Starts Acquisition Process of Arius to Gain Access to New Screening Platform for Antibody Therapeutics |
| July 23 |
Wyeth Reports Earnings Results for the 2008 Second Quarter and First Half and Raises Earnings Guidance |
| July 23 |
Pfizer Reports Second-Quarter 2008 Results |
| July 23 |
Progen Terminates Pathway Trial & Confirms Focus on Potential High Value Molecules and M&A |
| July 23 |
Dingell, Stupak to Investigate Ranbaxy Drug Approvals |
| July 23 |
GSK Sets Out New Strategic Priorities |
| July 23 |
Dan Troy Appointed as Senior Vice President and General Counsel for GlaxoSmithKline |
| July 23 |
GSK Enters Transformational Agreement with Aspen to Drive Growth in Emerging Markets |
| July 23 |
Erythropoietins: The Shift from Biosimilars to "more for less" ESAs |
| July 24 |
Alcon's Second Quarter Sales Rise 17.9 Percent; Net Earnings Increase 26.3 Percent |
| July 24 |
Lilly Reports Solid Second-Quarter Results |
| July 24 |
Bristol-Myers Squibb Continues Strong Financial Performance Led by Double-Digit Global Sales Growth |
| July 24 |
Pharmacopeia Advances Therapeutic Program with GlaxoSmithKline |
| July 24 |
Cohen Milstein Hausfeld & Toll P.L.L.C. Files Lawsuit Concerning Genentech Buyout |
| July 24 |
Solvay Pharmaceuticals S.A. Plans the Offer Period for Innogenetics from August 12 to September 5, 2008 |
| July 24 |
Biogenerics Would Reduce Health Care Costs for Patients, Says GPhA High Health Care Costs the Focus of Joint Economic Committee Hearing |
| July 25 |
Genentech Forms Special Committee of Independent Directors to Review Roche Proposal |
| July 25 |
With Drug Company Profits Soaring, Sen. Brown Renews Investigation of Drug Industry Outsourcing to China |
| July 25 |
Recommended Cash Offer for Acambis Plc by Sanofi Pasteur Holding |
| July 28 |
Ambrilia Provides Update on PPL-100 Partnership with Merck & Co., Inc. |
| July 29 |
Amgen's Second Quarter 2008 Adjusted Earnings Per Share Increased 2 Percent to $1.14 |
| July 29 |
Mylan Acquires Remaining Interest in Somerset Joint Venture From Watson |
| July 29 |
Harris Poll: Number of "Cyberchondriacs" - Adults Going Online for Health Information - Has Plateaued or Declined |
| July 29 |
Acusphere Announces Staff Reductions |
| July 29 |
Statins May Protect Against Memory Loss |
| July 29 |
Schweizerhall: Clopidogrel in Germany – Court Orders Immediate Execution of Approval |
| July 29 |
SDI Acquires Verispan |
| July 30 |
Clopidogrel in Germany |
| July 30 |
Bayer Continues Its Success |
| July 30 |
FDA Sends Letter to Baxter Over 'Clinical Thank You Email' |
| July 31 |
FDA Issues Complete Response Letters Ordering Safety Labeling Changes Under FDAAA for Aranesp, Epogen, and Procrit |
| July 31 |
Amgen Issues Statement in Response to Revised ESA Labeling Received from the FDA Today |
| July 31 |
Bristol-Myers Squibb Proposes to Acquire ImClone Systems for $60.00 Per Share in Cash |
| July 31 |
Sanofi-aventis News |
| July 31 |
Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade |
| July 31 |
AstraZeneca PLC Second Quarter and Half Year Results |
| July 31 |
Photos: Bayer Names New U.S. CEO |
